Immunotherapy has revolutionized the treatment of cancer in the last decade, yet many tumors do not respond to these new therapies. A new genome-wide screen of 20,000 human genes in T cells have turned up several new candidates ...
Aug 23, 2019
0
114
Mistakes in DNA are known to drive cancer growth. But a new study, from Washington University School of Medicine in St. Louis, heavily implicates a genetic phenomenon commonly known as "jumping genes" in the growth of tumors.
Apr 1, 2019
0
86
(Medical Xpress) -- Mice genetically programmed to develop prostate cancer had smaller, slower growing tumors if they consumed a diet containing walnuts, UC Davis researchers report in the current issue of the British Journal ...
Jan 25, 2012
0
1
Many cancer therapies do not produce the hoped-for results. A common reason for this is that the tumors develop resistance to the medications. This is the case, for example, with alpelisib, a drug that has been approved for ...
Apr 11, 2023
0
65
A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial—highlighting the potential of a new class of drugs known as ATR inhibitors.
Sep 29, 2020
0
95
Pancreatic cancers are among the most aggressive, deadly tumor types, and for years, researchers have struggled to develop effective drugs against the tumors. Now, Salk Institute researchers have identified a new set of molecules ...
Sep 6, 2023
1
53
Glioblastoma is the most common and most lethal form of brain tumor in people. Research published in the International Journal of Computational Biology and Drug Design offers a novel way to determine what biological functions ...
Jul 6, 2011
0
0
A new biodegradable gel improves the immune system's ability to keep cancer at bay after tumors are surgically removed.
Apr 6, 2022
0
76
A study has revealed that tumors can evade the immune system by telling immune cells to produce immunosuppressive steroids. Researchers from the Wellcome Sanger Institute, Department of Pathology, University of Cambridge, ...
Jul 30, 2020
0
12
(HealthDay)—Periocular basal cell carcinomas (pBCCs) have a mean growth rate of 11.2 mm² every 30 days, according to a study published in the April issue of the British Journal of Dermatology.
Apr 9, 2015
0
3
